About us

Catapult Life Science will contribute to activity and value creation in Norway, by providing facilities and expertise for research based product development. 

Catapult Life Science is a centre where small and large players can find equipment, space, infrastructure and expertise, so they can develop their products in Norway. We are based at Fornebu, to be near the leading Norwegian life science environments, including the University of Oslo and Oslo University Hospital. We realise the importance of proximity for a centre that will enable the first steps towards industrialisation for startup companies arising from this environment. In parallel, we are working for the establishment of a future Catapult Centre for Life Sciences in the Ullevål-Gaustadbekkdalen area, in connection with the relocation of the major knowledge institutions related to the coming Life Science building. 

We are bringing industry expertise in product development, regulatory requirements and market needs to the University and the research community, and enable mutual exchange of knowledge by collaborating with researchers and involving students and research fellows. We also aim to work with manufacturers so that they can take the products that have proven their potential to large-scale production in Norway. 

Through the network Life Science Pilot, businesses get access to competence beyond what the centre can offer. The network will accelerate product development and be a hotbed for new funding applications nationally and internationally.

Employees

Kristin Merete Schoultz

Kristin Merete Schoultz

CEO

kristin@katapult1.no

Kristin has a background as PhD in radiochemistry (1999) from the University of Oslo and University of Duke, North Carolina, USA. She has worked within the Nycomed-Amersham-GE Healhcare business in the period 1999  2010 with pharmacovigillance, clinical studies, QA within R&D, technologi transfer and commercials. Kristin has been QA Director Clavis Pharma  and Department Director Biophamaceutical production, Norwegian Institute of public health. She co-founded Catapult Life Science.  

Gro Helene Osnes

Gro Helene Osnes

Production and Project Manager

Gro Helene is an officially approved medical technologist, and has a Masters degree in biotechnology from NTNU in 2006. She has analytical experience within cytogenetics, cell differentiation/hematology and blood gas. From 2006, she has worked at Biopharmaceutical Production at the Norwegian Institute of Public Health with contract manufacturing of pharmaceuticals for clinical trials according to GMP and medical devices, as Production and Project manager.

Hanne C. Grøgaard

Hanne C. Grøgaard

Scientist Product Development

Hanne is a Master of science in Biotechnology from NTNU with a thesis in analytical chemistry at Sintef. She has worked with product development, analysis and production within cosmetics, feed and supplement in Aker Biomarine og NutraQ. She has been involved in sales, networking and customer training, and is now working on biological drug process characterization and production development at Diatec.

Goro Ligård

Goro Ligård

Microbiologist and QC-analyst

Goro is a Master of Science in Biotechnology with specialization in microbiology, from UMB. She has worked in the food industry as a quality coordinator, where she participated in internal audits and quality work. From 2012 – 2018, she worked according to GMP at the quality control unit at Biopharmaceutical Production at the Norwegian Institute of Public Health, and performed various microbiological analyses.

Anders Stokvold

Anders Stokvold

Laboratory Engineer

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Jhansi Panga

Jhansi Panga

Laboratory Engineer

Jhansi is master in Biochemistry from Andhra University in India 2009. She has worked as QA Assistant in Novartis Norway and as lab technician in Invicta, performing chemical analyses. She has also worked as Department Engineer at Biopharmaceutical Production at the Norwegian Institute of Public Health, with responsibility for archiving, environmental control and other GMP related work.

The Board

Trond Johansen

Trond Johansen

Chairman

Kjeld-Håkon Nilsen

Kjeld-Håkon Nilsen

Board member

Naja Dannow

Naja Dannow

Board member

Naja mainly deals with real estate transactions, lease agreements and agreements concerning purchase, sale and development of real estate, but she also has extensive experience within company and corporate law and other transactions than within real estate. Naja assists in all elements of a transaction process, including advice on choice of transaction form, contract negotiations, due diligence, company formalities and implementation and settlement. In addition, Naja holds particular competence in corporate governance.

Einar Jonsbu

Einar Jonsbu

Board member

Anders Stokvold

Anders Stokvold

Board member

Shareholders:

Founders:
Astrid Hilde Myrset, Kristin Meret Schoultz (CEO), Arne Wang Aabye, Erik Agner – Polypure AS, Bjørn Pedersen – Diatec Monoclonals AS

Institutional shareholders: 
IFE; Oslotech AS; SINTEF

TTO’s: 
Inven2 AS; Bergen Teknologioverføring AS; Kjeller Innovasjon AS

Largest private shareholders:

Myrlid AS, Micro LLC, Diatec Monoclonals AS, Jandersen Kapital AS, Kiritec AS, Anders Stokvold, André Svee, Kristin Merete Schoultz, SurViva AS, IFE Invest, Ola Halvorsen, Pedro Consulting AS, GE Healthcare AS, Arne Wang Aabye, Polypure AS og Idunn Sundfør.